1,128 research outputs found

    Investigating the IL-17 family and Th17-related cytokines in juvenile-onset systemic lupus erythematosus

    Get PDF
    Background: Juvenile-onset systemic lupus erythematosus (JSLE) is a multi-system autoimmune disease characterised by severe disease and poorer prognosis compared to adult-onset disease. Currently, its aetiopathogenesis is unknown but is postulated to be a result of a loss of peripheral tolerance. T helper 17 (Th17) cells produce pro-inflammatory cytokines Interleukin-17A (IL-17A) and IL-21 and are upregulated by IL-23. These cytokines have been shown to factor in the inflammatory manifestations of adult SLE. Six members of the IL-17 family have been identified so far, as well as IL-17 receptor subtypes. Although research on IL-17 family members is scarce, existing studies have implicated IL-17B, IL-17C and IL-17 receptor E (IL-17RE) in autoimmune pathology. Objective: To optimise the measurement of the IL-17 family (IL-17A, IL-17B, IL-17C and IL-17RE) and Th17-related cytokines (IL-21 and IL-23) in order to investigate their roles in the pathogenesis of JSLE. Methods: Peripheral blood components were isolated from JSLE, healthy paediatric control and juvenile idiopathic arthritis (JIA) patients. Spike-and-recovery validation experiments were conducted using JSLE and control serum and plasma in an IL-17A single plex and IL-17A, IL-21 and IL-23 ELISAs. mRNA expression of IL-17A was analysed by qPCR in CD4+ T cells from JSLE and control patients. Western blot analysis of IL-17A protein was optimised and measured in the PBMCs, CD4+ T cells and neutrophils of JSLE, control and JIA patients. JSLE and control PBMC mRNA expression of IL-17B, IL-17C and IL-17RE were quantified using qPCR, then mRNA expression of IL-17C and IL-17RE in CD3/CD28 stimulated JSLE and control PBMCs were analysed. Results: 102 patients (JSLE: n=31; healthy controls: n=66; JIA: n=4; lupus nephritis: n=1) were involved in this study, with multiple episode samples from JSLE and JIA patients. Poor recovery and matrix interference were detected in all IL-17A, IL-21 and IL-23 immunoassays. Protein IL-17A expression of neutrophils was significantly decreased in JSLE patients (p=0.03). IL-17A neutrophil expression was validated using purified neutrophils from healthy adult donors. IL-17B was not expressed in any samples. No significant differences were found between JSLE and control CD4+ cells or PBMCs at an mRNA and protein level for IL-17A, IL-17C or IL-17RE expression. IL-17RE expression was significantly decreased in stimulated JSLE PBMCs (p=0.007), with fold decreases in IL-17C and IL-17RE of JSLE relative to controls. Western blotting of IL-17C and IL-17RE protein expression was optimised in JSLE and control CD4+ T cells. Conclusions: Findings show IL-17A is not significantly increased in the peripheral blood of JSLE patients and that IL-17A is expressed by neutrophils. IL-17B is not expressed in human PBMCs while IL-17C and IL-17RE are, but are not significantly increased in JSLE PBMCs. Future immunoassays must be validated for recovery potential and existing data should be interpreted with caution. This study involved the validation and rigorous optimisation of novel methods investigating the IL-17 family and Th17-related cytokines, contributes significantly to limited research in the context of paediatric autoimmune disease, Th17 and the IL-17 family, and opens up new avenues for future directions in these fields

    Green energy technology

    Full text link
    Our environment is facing several serious challenges from energy utilization, such as fossil fuel exhaustion, air pollution, deteriorated atmospheric greenhouse effect, global warming, climate change, etc [...]</jats:p

    Brief report: the utilization of influencing tactics for the implementation of infection control policies.

    Get PDF
    published_or_final_versio

    Hypoxia increases neutrophil-driven matrix destruction after exposure to Mycobacterium tuberculosis.

    Get PDF
    The importance of neutrophils in the pathology of tuberculosis (TB) has been recently established. We demonstrated that TB lesions in man are hypoxic, but how neutrophils in hypoxia influence lung tissue damage is unknown. We investigated the effect of hypoxia on neutrophil-derived enzymes and tissue destruction in TB. Human neutrophils were stimulated with M. tuberculosis (M.tb) or conditioned media from M.tb-infected monocytes (CoMTB). Neutrophil matrix metalloproteinase-8/-9 and elastase secretion were analysed by luminex array and gelatin zymography, gene expression by qPCR and cell viability by flow cytometry. Matrix destruction was investigated by confocal microscopy and functional assays and neutrophil extracellular traps (NETs) by fluorescence assay. In hypoxia, neutrophil MMP-8 secretion and gene expression were up-regulated by CoMTB. MMP-9 activity and neutrophil elastase (NE) secretion were also increased in hypoxia. Hypoxia inhibited NET formation and both neutrophil apoptosis and necrosis after direct stimulation by M.tb. Hypoxia increased TB-dependent neutrophil-mediated matrix destruction of Type I collagen, gelatin and elastin, the main structural proteins of the human lung. Dimethyloxalylglycin (DMOG), which stabilizes hypoxia-inducible factor-1α, increased neutrophil MMP-8 and -9 secretion. Hypoxia in our cellular model of TB up-regulated pathways that increase neutrophil secretion of MMPs that are implicated in matrix destruction

    Grb2 monomer-dimer equilibrium determines normal versus oncogenic function

    Get PDF
    The adaptor protein growth factor receptor-bound protein 2 (Grb2) is ubiquitously expressed in eukaryotic cells and involved in a multitude of intracellular protein interactions. Grb2 plays a pivotal role in tyrosine kinase-mediated signal transduction including linking receptor tyrosine kinases to the Ras/mitogen-activated protein (MAP) kinase pathway, which is implicated in oncogenic outcome. Grb2 exists in a constitutive equilibrium between monomeric and dimeric states. Here we show that only monomeric Grb2 is capable of binding to SOS and upregulating MAP kinase signalling and that the dimeric state is inhibitory to this process. Phosphorylation of tyrosine 160 (Y160) on Grb2, or binding of a tyrosylphosphate-containing ligand to the SH2 domain of Grb2, results in dimer dissociation. Phosphorylation of Y160 on Grb2 is readily detectable in the malignant forms of human prostate, colon and breast cancers. The self-association/dissociation of Grb2 represents a switch that regulates MAP kinase activity and hence controls cancer progression

    Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo

    Get PDF
    Endothelial cell survival is indispensable to maintain endothelial integrity and initiate new vessel formation. We investigated the role of SHP-2 in endothelial cell survival and angiogenesis in vitro as well as in vivo. SHP-2 function in cultured human umbilical vein and human dermal microvascular endothelial cells was inhibited by either silencing the protein expression with antisense-oligodesoxynucleotides or treatment with a pharmacological inhibitor (PtpI IV). SHP-2 inhibition impaired capillary-like structure formation (p < 0.01; n = 8) in vitro as well as new vessel growth ex vivo (p < 0.05; n = 10) and in vivo in the chicken chorioallantoic membrane (p < 0.01, n = 4). Additionally, SHP-2 knock-down abrogated fibroblast growth factor 2 (FGF-2)-dependent endothelial proliferation measured by MTT reduction ( p ! 0.01; n = 12). The inhibitory effect of SHP-2 knock-down on vessel growth was mediated by increased endothelial apoptosis ( annexin V staining, p ! 0.05, n = 9), which was associated with reduced FGF-2-induced phosphorylation of phosphatidylinositol 3-kinase (PI3-K), Akt and extracellular regulated kinase 1/2 (ERK1/2) and involved diminished ERK1/2 phosphorylation after PI3-K inhibition (n=3). These results suggest that SHP-2 regulates endothelial cell survival through PI3-K-Akt and mitogen-activated protein kinase pathways thereby strongly affecting new vessel formation. Thus, SHP-2 exhibits a pivotal role in angiogenesis and may represent an interesting target for therapeutic approaches controlling vessel growth. Copyright (C) 2007 S. Karger AG, Basel

    Molecular Networks in FGF Signaling: Flotillin-1 and Cbl-Associated Protein Compete for the Binding to Fibroblast Growth Factor Receptor Substrate 2

    Get PDF
    Fibroblast growth factor receptor substrate 2 (FRS2α) is a signaling adaptor protein that regulates downstream signaling of many receptor tyrosine kinases. During signal transduction, FRS2 can be both tyrosine and threonine phosphorylated and forms signaling complexes with other adaptor proteins and tyrosine phosphatases. We have here identified flotillin-1 and the cbl-associated protein/ponsin (CAP) as novel interaction partners of FRS2. Flotillin-1 binds to the phosphotyrosine binding domain (PTB) of FRS2 and competes for the binding with the fibroblast growth factor receptor. Flotillin-1 knockdown results in increased Tyr phosphorylation of FRS2, in line with the inhibition of ERK activity in the absence of flotillin-1. CAP directly interacts with FRS2 by means of its sorbin homology (SoHo) domain, which has previously been shown to interact with flotillin-1. In addition, the third SH3 domain in CAP binds to FRS2. Due to the overlapping binding domains, CAP and flotillin-1 appear to compete for the binding to FRS2. Thus, our results reveal a novel signaling network containing FRS2, CAP and flotillin-1, whose successive interactions are most likely required to regulate receptor tyrosine kinase signaling, especially the mitogen activated protein kinase pathway

    Selection of Oncogenic Mutant Clones in Normal Human Skin Varies with Body Site

    Get PDF
    Skin cancer risk varies substantially across the body, yet how this relates to the mutations found in normal skin is unknown. Here we mapped mutant clones in skin from high- and low-risk sites. The density of mutations varied by location. The prevalence of NOTCH1 and FAT1 mutations in forearm, trunk, and leg skin was similar to that in keratinocyte cancers. Most mutations were caused by ultraviolet light, but mutational signature analysis suggested differences in DNA-repair processes between sites. Eleven mutant genes were under positive selection, with TP53 preferentially selected in the head and FAT1 in the leg. Fine-scale mapping revealed 10% of clones had copy-number alterations. Analysis of hair follicles showed mutations in the upper follicle resembled adjacent skin, but the lower follicle was sparsely mutated. Normal skin is a dense patchwork of mutant clones arising from competitive selection that varies by location. / Significance: Mapping mutant clones across the body reveals normal skin is a dense patchwork of mutant cells. The variation in cancer risk between sites substantially exceeds that in mutant clone density. More generally, mutant genes cannot be assigned as cancer drivers until their prevalence in normal tissue is known
    corecore